Highest-materiality recent filing
HR subsidiary issues $700M 3.00% exchangeable senior notes due 2032
Issued $700M aggregate principal of 3.00% exchangeable notes due Jan 15, 2032; initial exchange price ~$23.01/share.
Healthcare Realty prices upsized $600M exchangeable notes at 3.00%, repays 2026 notes
Offer upsized from $500M to $600M; initial purchasers have option for additional $100M.
Healthcare Realty Q1 Normalized FFO $0.41; raises FY 2026 guidance on strong leasing
GAAP net loss improved to $(0.00)/share from $(0.13) YoY; Normalized FFO $0.41 (vs $0.39 prior year).
Normalized FFO per share $1.61, up 3% YoY; same-store cash NOI growth 4.8% (vs 3.5%–4.5% guidance midpoint).
Healthcare Realty Q4 NAREIT FFO $0.36/sh; guides 2026 Normalized FFO $1.58-$1.64
GAAP net income $0.04/sh (Q4); full-year GAAP net loss $(0.71)/sh on $246M loss.
Healthcare Realty Trust appoints Daniel Gabbay as CFO; Austen Helfrich departs
Daniel Gabbay named EVP and CFO effective Jan 12, 2026; previously MD at RBC Capital Markets covering healthcare REITs.
Healthcare Realty Q3 Normalized FFO $0.41, raises 2025 guidance, $404M asset sales closed
GAAP net loss ($0.17)/shr vs ($0.26) YoY; Normalized FFO $0.41, NAREIT FFO $0.34.
Healthcare Realty enters $2.615B credit facility, extends revolver maturity to 2029
$1.5B unsecured revolver extended from Oct 2025 to July 2029, with two six-month extension options.
Healthcare Realty reports Q2 GAAP loss of $0.45/share; cuts dividend 23%, raises NFFO guidance
GAAP net loss of $(0.45) per share vs $(0.39) in Q2 2024; Normalized FFO $0.41 per share.
Healthcare Realty reports Q1 net loss of $44.9M; normalized FFO $0.39; appoints new CEO
Net loss attributable to common stockholders of $44.9M ($0.13 diluted EPS); Normalized FFO per share $0.39.
Healthcare Realty appoints Peter A. Scott as President and CEO effective April 15, 2025
Peter A. Scott, former CFO of Healthpeak Properties, appointed as President and CEO, effective April 15, 2025.
HR Q4 net loss $0.31/sh; normalized FFO $0.40 at high end; guides 2025 FFO $1.56-$1.60
Net loss attributable to common stockholders $(106.8)M ($0.31/diluted share) for Q4 2024.
Healthcare Realty appoints three new directors under Starboard pact; Bohjalian Chair
Appointed David Henry, Glenn Rufrano, Don Wood to board, effective Dec 8, 2024, under cooperation agreement with Starboard Value.
Healthcare Realty CEO Todd Meredith steps down; Constance Moore named interim CEO
Meredith departed as President/CEO and director effective Nov 11, 2024; board reduced to 11 members.
HR Q3 net loss $93M, Normalized FFO $0.39; guidance mixed
Net loss attributable to common stockholders $93.0M ($0.26 per diluted share).
Healthcare Realty Trust announces CFO departure, appoints interim CFO and new COO, CAO, CIO
CFO Kris Douglas departs effective Oct 1, 2024; severance ~$2.9M, equity acceleration of 342,016 shares, Q3 charge $6.5-$7.5M.
Healthcare Realty expands Nuveen JV by $193M; YTD proceeds ~$700M
Contributed eight properties for $193M into existing Nuveen JV; 80/20 structure; ~40% secured financing.
Healthcare Realty expands KKR JV with $118M property contribution; proceeds ~$94M
Contributed $118M of additional properties to its KKR joint venture, generating approximately $94M in proceeds.
Healthcare Realty Q2 normalized FFO $0.38; raises 2024 guidance to $1.53-$1.58
Q2 net loss to common stockholders $143.8M ($0.39 diluted); normalized FFO $0.38 per share ($0.39 excl. $3M Steward reserves).
Healthcare Realty Q2 net loss $143.8M; normalized FFO $0.38; affirms 2024 guidance
Net loss $143.8M ($0.39/sh); normalized FFO $0.38/sh, $0.39 ex-Steward reserves.
Signed 432K sq ft of new multi-tenant leases in Q2 (4th consecutive >400K); 1H absorption 183K sq ft, above 90-140K guidance.
Generated ~$400M from JV/asset sales YTD; additional deals expected to bring total proceeds to >$1B, majority closing in Q3.
Healthcare Realty appoints Thomas N. Bohjalian to Board, adds Capital Allocation Committee seat
Thomas N. Bohjalian appointed to Board effective June 25, 2024; Board expanded to 12 directors.
Healthcare Realty Trust provides JV progress, $227M proceeds, $175M+ share repurchases
Contributed 10 properties to KKR JV generating $227M proceeds; expects total >$300M from additional contributions.
Healthcare Realty Q1 net loss $310.8M; announces $383M JV with KKR, share buyback
Q1 net loss $310.8M ($0.82/diluted); Normalized FFO $0.39 per share.
Healthcare Realty forms JV with KKR; receives ~$300M from seed portfolio, KKR commits $600M
Contributes 12 MOB properties valued at $382.5M (6.6% cap rate) to JV, receives ~$300M proceeds.
Healthcare Realty reports Q4 net loss of $40.5M; Normalized FFO $0.39; guides FY2024 $1.52-$1.58
Q4 net loss $40.5M ($0.11/sh); Normalized FFO $150.7M ($0.39/sh).
Healthcare Realty Trust reports Q3 net loss of $67.8M; normalized FFO $0.39/share
Net loss of $67.8M ($0.18/share); Normalized FFO of $148.1M ($0.39/share).
Healthcare Realty Trust updates on $318M YTD dispositions and record Q3 leasing of 447K sq ft
Completed $209M in asset sales since June 2023; YTD dispositions total $318M.
Healthcare Realty Trust Q2 net loss $82.8M, normalized FFO $0.39/share
Net loss of $82.8M ($0.22 diluted EPS); Normalized FFO of $149.8M ($0.39 diluted).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”) approved the appointment of Peter A. Scott to serve as a director.
On April 1, 2025, the Board of Directors of Healthcare Realty Trust Incorporated (the “Company”) appointed Peter A. Scott as the Company’s President and Chief Executive Officer, effective April 15, 2025.
on December 31, 2024, the Company entered into a Fourth Amended and Restated Employment Agreement with Mr. Bryant relating to his service as Senior Vice President, Legal Affairs of the Company.
The board of directors of the Company has appointed Constance B. Moore to serve as the Company's Interim President and Chief Executive Officer effective November 11, 2024.
On November 11, 2024, Healthcare Realty Trust Incorporated (the "Company") and Todd J. Meredith determined that Mr. Meredith would depart from his position as President and Chief Executive Officer of the Company, effective November 11, 2024.
The Board of Directors of the Company has appointed Austen B. Helfrich to serve as the Company’s Interim Chief Financial Officer effective October 1, 2024.
On September 10, 2024, Healthcare Realty Trust Incorporated (the “Company”) and J. Christopher Douglas determined that Mr. Douglas would depart from his position as Executive Vice President and Chief Financial Officer of the Company, effective October 1, 2024.
Max materiality 0.85 · Median 0.65 · Most common event other_material